“keryx-biopharmaceuticals” Archives

Entry Author Date Location
Tricida Grabs $30M Series B for Chronic Kidney Disease Treatment 03/04/15 San Francisco
Foresite Capital Reloads With New $300M Late-Stage Biotech Fund 04/01/14 San Francisco
East Coast Life Sciences Roundup: Sarepta, Vertex, Celsion, More 02/01/13 Boston
Keryx Finally Succeeds With a Clinical Trial, for Kidney Disease Drug 01/28/13 New York
Undaunted by Wall Street “Penalty Box,” Keryx Focuses on Kidney Drug 05/22/12 New York
Page 1 of 1